FountainVest Partners
FountainVest is a private equity funds dedicated to completely China. They seek to invest in industry leaders and emerging leaders with a
Business Model:
Revenue: $30M
Employees: 51-200
Rankings
Industries / Tags:
Detailed FountainVest Partners Information
Geographic Data
Address: 3 Garden Road
City: Central
State: hong kong special administrative region
Zip: 400062
Country: CN
Financial Info
Stage:
Raised Last:
$0
Raised Total:$9B
Social
Linkedin
Crunchbase
Metrics
4,418,845Website Global Rank
2,240Website Monthly Traffic
Twitter Followers
Description
FountainVest is a private equity funds dedicated to completely China. They seek to invest in industry leaders and emerging leaders with a strong track record delivering high growth.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 4/2021 | Plus | Series D | 0 |
| 11/2019 | LBX Pharmacy | Post-IPO Secondary | 557M |
| 4/2011 | Enzo Jewelry | Private Equity Round | - |
| 5/2016 | Codoon | Series C | 0 |
| 10/2015 | FangDD | Series C | 223M |
| 1/2018 | Chehaoduo | Series C | 0 |
| 1/2021 | Broncus Technologies | Series D | - |
| 1/2011 | L.K. Technology | Post-IPO Equity | - |
| 6/2020 | Zuoyebang | Series E | 0 |
| 2/2021 | Xingsheng Youxuan | Series D | 0 |
| 3/2010 | SPH KYUAN | Series E | 80M |
| 1/2020 | Maoyan | Post-IPO Equity | - |
| 12/2020 | Zuoyebang | Series E | 0 |
| 1/2021 | 4Paradigm | Series D | 0 |
| 3/2015 | Dazhong Dianping | Series E | 850M |
| 5/2013 | Focus Media | Private Equity Round | - |
| 7/2015 | Xingren Doctor | Series B | 32M |
| 1/2019 | Antengene Corporation | Series B | 0 |
| 3/2021 | USHOPAL | Series D | 100M |
| 11/2008 | Universtar Science &a; Technology | Series B | - |
| 1/2013 | Yantai Beacon Medical | Private Equity Round | - |
| 4/2021 | Plus | Series D | 0 |
| 3/2021 | USHOPAL | Series D | 0 |
| 2/2021 | Xingsheng Youxuan | Series D | 0 |
| 1/2021 | Broncus Technologies | Series D | - |
| 1/2021 | 4Paradigm | Series D | 0 |
| 12/2020 | Zuoyebang | Series E | 0 |
| 6/2020 | Zuoyebang | Series E | 0 |
| 1/2020 | Maoyan | Post-IPO Equity | - |
| 11/2019 | LBX Pharmacy | Post-IPO Secondary | 0 |
| 1/2019 | Antengene Corporation | Series B | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
